Response to "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX"

Authors

• Harrison P Nguyen
• Eingun James Song
• Edward Ted Lain
• Jeffrey M Sobell
• Linda F. Stein Gold, Henry Ford HealthFollow
• Mark G Lebwohl

Recommended Citation

Nguyen HP, Song EJ, Lain ET, Sobell JM, Stein-Gold L, Lebwohl MG. Response to "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX". J Am Acad Dermatol. 2026;95(2):223.

Document Type

Article

Publication Date

8-1-2026

Publication Title

Journal of the American Academy of Dermatology

PubMed ID

42036026

ePublication

ePub ahead of print

Volume

95

Issue

2

First Page

223

Last Page

223